The Myoglobin test is a rapid chromatographic immunoassay for the qualitative detection of human Myoglobin in whole blood, serum, or plasma as an aid in the diagnosis of myocardial infarction (MI). This test utilizes a combination of antibody-coated particles and captures reagents to qualitatively detect myoglobin at a limit of detection (LOD) of 50 ng/mL. Myoglobin (MYO) is a protein released into the bloodstream after cardiac injury. Myoglobin is a heme protein normally found in skeletal and cardiac muscle with a molecular weight of 17.8 kDa. It constitutes about 2 percent of total muscle protein and is responsible for transporting oxygen within muscle cells. When muscle cells are damaged, Myoglobin is released into the blood rapidly due to its relatively small size. The level of Myoglobin increases measurably above baseline within 2 - 4 hours post-infarct, peaking at 9 - 12 hours, and returning to baseline within 24 - 36 hours.
 bio-equip.cn
Zhejiang Orient Gene Biotech Co., Ltd specializes in the R&D, production, and sales of in vitro diagnostic products in the field of high-end medical equipment and devices.
Currently, its main products are POCT instant diagnostic reagents, which are mainly used in the detection of infectious diseases (including COVID-19 detection products), drugs of abuse, fertility, tumor marker and cardiac marker detection, among which infectious disease and drugs of abuse detection are the two core product series of the company.
The company’s sales network has been extended to more than 120 countries and regions, and its overseas sales revenue accounted for 95% in 2019. At present, the company has obtained more than 300 overseas certifications/records, and more than 70 domestic registration/record certificates.
|
中文
